88% of users IMPROVED: Were found to have INCREASED or IMPROVED Cognitive function (68%), while an additional (20%) experienced LESS Cognitive decline (over the 1yr period that is NORMAL for this disease & population)! Get your FACTS straight bud! https://finance.yahoo.com/news/cassava-sciences-simufilam-data-shows-151627193.html Phase 3 Trials already posted here: https://clinicaltrials.gov/ct2/show/NCT04994483?term=cassava+sciences&draw=2&rank=1 https://clinicaltrials.gov/ct2/show/NCT05026177?term=cassava+sciences&draw=2&rank=2